Information Provided By: 
Fly News Breaks for November 9, 2018
ENDP
Nov 9, 2018 | 07:31 EDT
Canaccord analyst Dewey Steadman upgraded Endo to Buy from Hold following its "beat and raise" quarter. He noted the strength was in its injectables and branded businesses and sees the recent pullback in the shares as a buying opportunity. Stedman raised his price target to $20 from $16 on Endo shares.
News For ENDP From the Last 2 Days
There are no results for your query ENDP
